Tag: Immunotherapy restrictions

Home / Immunotherapy restrictions

Categories

FDA revises pembrolizumab’s indication for gastric cancer

The Food and Drug Administration updated the approved use of pembrolizumab (Keytruda, Merck) in combination with trastuzumab, fluoropyrimidine, and platinum-containing chemotherapy for treating HER2...
immunotherapy-restrictions

Scan the code